Why did the FDA snub CBD (again)?
A piece in Cannabis Wire offers some insight into the FDA's decision to reject CBD's use as a dietary supplement. Essentially, the agency doesn't want to approve CBD as a additive to mainstream products when it's also the active ingredient in Epidiolex, a pharmaceutical the agency has approved to treat severe pediatric epilepsy disorders.
